Clarus Ventures

American biotherapeutics-focused fund with a barbell investment strategy between early stage disruptive platforms and Phase III defined exit deals

Genesys Capital

Toronto & Montreal based early stage life sciences fund focused on building companies in the high-growth sectors of healthcare and biotechnology

Zymeworks

Zymeworks is a biotherapeutics company that is developing best-in-class Azymetric bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases